Clinical Trials Browser

OTHER × pamiparib × Genitourinary × Clear all

NCT06387056 2024-04-26

SEGNO

Phase 2 Recruiting

Locally Advanced Prostate Cancer

NCT04603365 2023-05-17

Pamiparib and Temozolomide for the Treatment of Hereditary Leiomyomatosis and Renal Cell Cancer

Phase 2 Withdrawn

Hereditary leiomyomatosis and renal cell cancer, Carcinoma, Renal Cell

NCT05327621 2022-04-14

Pamiparib in mCRPC With HRD or BRCA1/2 Mutation

Phase 2 Unknown

Metastatic Castration-resistant Prostate Cancer